Difference between revisions of "Pediatric Lomustine Dosing Chart"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
(Created page with "{{#lst:Section editor transclusions|peds}} <big>''This page contains studies that were specific to pediatric populations. For the more general AML page, follow Acute myeloid...")
 
(Merged content into main Lomustine page and replaced this page with a redirect)
Tag: New redirect
 
(7 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{#lst:Section editor transclusions|peds}}
+
#REDIRECT [[Lomustine_(CCNU)]]
<big>''This page contains studies that were specific to pediatric populations. For the more general AML page, follow [[Acute myeloid leukemia|this link]].</big>
 
{| class="wikitable" style="float:right; margin-right: 5px;"
 
|-
 
|<div style="background-color: #fee0d1; border: 1px solid #808000; padding: 5px; {{border-radius|16px}}" align="right"><font size="4"><b>{{#ask: [[-Has subobject::{{FULLPAGENAME}}]] |?Regimen |limit=10000|format=sum}} [[Tutorial#Regimens|regimens]] on this page</b></font></div>
 
<div style="background-color: #deebf6; border: 1px solid #808000; padding: 5px; {{border-radius|16px}}"><font size="4"><b>{{#ask: [[-Has subobject::{{FULLPAGENAME}}]] |?Variant |limit=10000|format=sum}} [[Tutorial#Variants|variants]] on this page</b></font></div>
 
|}
 
{{TOC limit|limit=3}}
 
 
 
=AAML1031 Sorafenib Dosing Nomogram=
 
 
 
{| class="wikitable" style="width: 40%; text-align:center;"
 
! style="width: 25%" |Body Surface Area (m<sup>2</sup>)
 
! style="width: 25%" |Ideal Dose (75 mg/m<sup>2</sup>/day once daily)
 
! style="width: 25%" |Actual Dose to be Given (200 mg/m<sup>2</sup>/day once daily)
 
|-
 
|2.0
 
|150 mg,
 
|150 mg
 
|-
 
|1.9
 
|143
 
|140
 
|-
 
|1.8
 
|135
 
|130
 
|-
 
|1.7
 
|128
 
|130
 
|-
 
|1.6
 
|120
 
|120
 
|-
 
|1.5
 
|112
 
|110
 
|-
 
|1.4
 
|105
 
|100
 
|-
 
|1.3
 
|98
 
|100
 
|-
 
|1.2
 
|90
 
|90
 
|-
 
|1.1
 
|82
 
|80
 
|-
 
|1.0
 
|75
 
|80
 
|-
 
|0.95
 
|71
 
|70
 
|-
 
|0.9
 
|68
 
|70
 
|-
 
|0.85
 
|64
 
|60
 
|-
 
|0.8
 
|60
 
|60
 
|-
 
|0.75
 
|56
 
|60
 
|-
 
|0.7
 
|53
 
|50
 
|-
 
|0.65
 
|49
 
|50
 
|-
 
|0.6
 
|45
 
|40
 
|-
 
|0.55
 
|41
 
|40
 
|-
 
|0.5
 
|38
 
|40
 
|-
 
|0.45
 
|34
 
|30
 
|-
 
|0.4
 
|30
 
|30
 
|-
 
|0.35
 
|26
 
|30
 
|-
 
|0.3
 
|23
 
|20
 
|}
 

Latest revision as of 05:42, 4 February 2022

Redirect to: